The Food Industry’s AI Opportunity Is Bigger Than Automation

Artificial intelligence is being integrated into agriculture, food manufacturing, supply chains and nutrition services, but its practical value depends on where it is applied. Agrifood companies face a wide range of possible uses, from measuring nutrient content in crops to redesigning products and supporting personalised diets. A major challenge is separating credible opportunities from broad promises.

A study titled "Prioritizing Artificial Intelligence Opportunities for Food as Health in the U.S. Agrifood Value Chain" examines this question through the United States as a case study. Written by Lourival Carmo Monaco Neto and Allan W. Gray of Purdue University and published in the journal Foods, the research maps food-as-health opportunities across the agrifood value chain and assesses how far current AI can address them.

The U.S. focus provides a defined setting for the analysis, but the underlying issues are global. Agrifood systems everywhere face demands for healthier products, more sustainable production, stronger traceability and better integration with public health. The availability of AI tools is expanding rapidly, while the institutions needed to verify claims, reward producers and protect consumers remain uneven.

Food's Health Value Begins Before It Reaches the Consumer

The study argues that the most important food-as-health opportunities are concentrated in agricultural production and food manufacturing. These are the segments that directly shape the nutritional, environmental and functional attributes of food.

Production choices influence crop characteristics, nutrient density, soil conditions and the sustainability of farming practices. Manufacturing decisions determine how much of that value survives processing, how products are reformulated and how nutritional benefits are communicated to consumers.

Other parts of the value chain remain essential, but their role is generally shaped by requirements created upstream. Input suppliers may develop seeds or ingredients with improved traits, while logistics providers and retailers help preserve, verify or distribute the resulting products.

This distinction has strategic importance. Agrifood firms often approach AI by asking which operations can be automated. The research suggests a more useful question: where is health-related value created, and what prevents producers or manufacturers from measuring, improving or capturing it?

The study's review identifies five broad areas of food-as-health activity: food quality and health outcomes; sustainable agriculture; food access and community systems; food as medicine; and consumer behaviour. These themes connect farm-level production with clinical nutrition, food purchasing and public health.

The wider implication is that nutritional value is not fixed. It can be influenced by seed selection, farm management, processing, formulation, distribution and consumer access. Health-oriented innovation therefore requires coordination across the chain rather than isolated product claims.

AI Is Most Useful When It Can Measure What the Market Cannot See

The strongest evidence in the study concerns AI applications for sensing, measurement, prediction and verification.

Machine-learning systems can analyse visible, near-infrared and hyperspectral data to estimate nutritional and quality attributes without destroying food samples. Satellite imagery and unmanned aerial vehicles can help monitor field conditions, crop quality and nutrient status. Genomic selection can support the development of varieties with improved nutritional characteristics.

These applications address a central problem identified by agricultural practitioners: producers may create health-related value without having affordable or reliable systems to document it. Without credible measurement, buyers cannot easily distinguish health-attributed commodities from conventional ones, and farmers have little basis for receiving a premium.

AI-supported traceability can extend measurement from the farm to the finished product. Combined with sensors, Internet of Things devices and distributed ledgers, it can support provenance tracking, authentication, fraud detection and food-safety risk assessment.

Technical capability alone will not solve the problem. Traceability systems verify what has been measured and recorded; they cannot guarantee that the original data were accurate. Interoperability, common standards, data ownership and cooperation among supply-chain partners will determine whether these systems create real value.

The global relevance is clear. Small farmers and food producers in developing countries often struggle to meet documentation requirements imposed by large buyers and export markets. Shared measurement infrastructure, cooperative data platforms and public support could help prevent AI-enabled traceability from becoming an advantage available only to the largest companies.

Product Design, Personalised Nutrition and Regulation Are Entering the AI Era

Food manufacturers face growing pressure to reformulate products while maintaining taste, texture, affordability and shelf life. They may need to reduce salt, sugar or other ingredients, replace inputs, meet clean-label expectations and comply with changing regulations across markets.

The study finds strong evidence for AI-assisted product design. Predictive models can estimate sensory, nutritional and functional properties, allowing companies to test potential formulations digitally before investing in physical prototypes. Generative tools can suggest ingredient substitutions and help explore alternative formulations.

AI can also support alternative-protein development and process optimisation. Its main demonstrated advantage is narrowing the range of options that researchers need to test. Laboratory and commercial validation remain necessary because a model cannot fully predict how a product will perform in real manufacturing or consumer settings.

Personalised nutrition represents another significant area. AI can combine dietary, behavioural and biological information to generate tailored recommendations or predict outcomes for defined groups. These capabilities could help connect food producers with healthcare providers and support Food as Medicine programmes.

The commercial opportunity depends on credible evidence. Payers, clinicians and consumers need to know whether a product improves outcomes for a particular population. AI may help identify target groups and analyse results, but clinical deployment involves privacy, safety and regulatory requirements that are more demanding than those attached to ordinary product development.

Regulatory intelligence is promising but less mature. Language models can search rules, extract obligations and monitor changes across jurisdictions. They could reduce the manual work involved in compliance, especially for companies managing large product portfolios.

The risks are significant. Current systems can hallucinate, fabricate references or misjudge the quality of scientific evidence. AI can assist with initial screening and information retrieval, but human experts must remain responsible for health claims and regulatory decisions.

The Biggest Barrier Is Not Computational

The study's most important finding may be the one that AI cannot address. Agricultural producers and food manufacturers both identified a need for durable, multi-year commercial commitments.

Farmers are reluctant to invest in health-oriented production systems when buyers will not guarantee demand or a price premium. Manufacturers may want improved and traceable inputs but often operate under annual purchasing arrangements focused on short-term price competition. The result is a symmetrical long-term-contract gap. Both sides need longer commitments to finance investment, but neither can create those commitments alone. The problem is relational and contractual rather than technological.

AI can reduce the information costs involved in such agreements. Better measurement can make nutritional and environmental attributes more visible, while traceability can improve verification and regulatory analysis. AI cannot create market demand, distribute risk fairly or persuade buyers and suppliers to accept longer horizons.

Governments and development agencies can help by investing in shared measurement systems, developing standards for health-related claims and supporting contract models that reward verified improvements. Public procurement, institutional food programmes and healthcare partnerships could also create more predictable demand.

Smaller producers will require particular attention. AI systems depend on data, calibration and computing capacity, all of which are unevenly distributed. Without public or cooperative infrastructure, the technology could widen the gap between large agribusiness firms and smaller farms.

Policy Relevance and Global Implications

The study connects directly with SDG 2 on food security and nutrition, SDG 3 on health, SDG 9 on innovation and infrastructure, and SDG 12 on responsible consumption and production.

• The key lesson for policymakers is to treat AI as one layer of a wider food-system strategy. Investment in digital tools should be accompanied by support for agricultural measurement, research validation, consumer protection, data governance and fair market access.
• For businesses, the priority should be applications tied to clear operational needs: measuring food attributes, tracing products, improving formulations and supporting evidence-based nutrition services. Companies should be cautious about deploying language models in areas where inaccurate outputs could create health or legal risks.
• For investors, the emerging opportunity is not limited to software. It includes sensing equipment, laboratory infrastructure, data standards, traceability platforms, testing services and new commercial models linking producers with health-oriented buyers.

The evidence base also has important limits. The research is focused on the United States, and the practitioner component involved a relatively small number of senior participants, including seven focal practitioners across six structured sessions. Participants were recruited through university and industry networks, which may favour firms already interested in food-as-health innovation.

The systematic review included a heterogeneous set of studies, while the AI assessment was a structured reading of existing literature rather than a field deployment study. The findings therefore identify credible opportunities and technological capabilities, but they do not establish that every application is commercially viable or transferable to other regulatory and economic environments.

Future research should test these applications in real settings, particularly on-farm sensing, farm-to-fork traceability and AI-assisted reformulation. Studies should measure costs, accuracy across regions and crops, effects on small producers, consumer outcomes and the willingness of firms to share data.

The food-and-health transition will not be achieved by placing an AI system at every point in the supply chain. It will depend on whether producers are rewarded for creating health value, whether manufacturers can verify it, whether regulators can trust the evidence and whether consumers can make informed choices.